Theophylline and Systemic Corticosteroids in COPD: The TASCS Trial

Christine Jenkins; Fuqiang Wen; Peter J Barnes; Bartolomé R. Celli; Nanshan Zhong; Jinping Zheng; Allison Martin; Norbert Berend

doi:10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7444

Related publications

Article2020

The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial

Christine Jenkins, Fuqiang Wen, Allison Martin, Peter J Barnes, Bartolomé R. Celli, Nanshan Zhong, Jinping Zheng, Anish Scaria, Gian Luca Di Tanna, Thomas Bradbury, Norbert Berend

Article2022

Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial

Thomas Bradbury, Gian Luca Di Tanna, Anish Scaria, Allison Martin, Fuqiang Wen, Nanshan Zhong, Jinping Zheng, Peter J Barnes, Bartolomé R. Celli, Norbert Berend, Christine Jenkins

Article2018

Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD

Graham Devereux, Seonaidh Cotton, Shona Fielding, Nicola McMeekin, Peter J Barnes, Andrew Briggs, Graham Burns, Rekha Chaudhuri, Henry Chrystyn, Lisa Davies, Anthony De Soyza, Simon Gompertz, John Haughney, Karen Innes, Joanna Kaniewska, Amanda Lee, Alyn H. Morice, John Norrie, A. Sullivan, Andrew M. Wilson, David Price

Letter2006

Theophylline for COPD

Peter J Barnes

Letter2009

Inhaled corticosteroids in COPD: the case against

Samy Suissa, Peter J Barnes